Antonio B. Colombo
Advanced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Dr. Antonio B. Colombo

Cardiology | Interventional Cardiology
161 Fort Washington Ave, 
New York, NY 
Advanced in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
161 Fort Washington Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Antonio Colombo is a Cardiologist and an Interventional Cardiologist in New York, New York. Dr. Colombo is rated as an Advanced provider by MediFind in the treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. His top areas of expertise are Coronary Heart Disease, Aortic Valve Stenosis, Tricuspid Regurgitation, Percutaneous Coronary Intervention (PCI), and Angioplasty.

His clinical research consists of co-authoring 1061 peer reviewed articles and participating in 16 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.

Specialties
Cardiology
Interventional Cardiology
Licenses
Internal Medicine in CT
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

161 Fort Washington Ave, New York, NY 10032

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

15 Clinical Trials

Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2025
Intervention Type: Device
Study Phase: Not Applicable
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
AMPLATZER™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 26, 2025
Intervention Type: Device
Study Phase: Not Applicable
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClip™ Device
An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated with the Abbott TriClip™ Device
Enrollment Status: Active_not_recruiting
Publish Date: January 08, 2025
Intervention Type: Device
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Enrollment Status: Active_not_recruiting
Publish Date: January 01, 2025
Intervention Type: Device
Trial to Evaluate Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater Tricuspid Regurgitation (TRILUMINATE)
Trial to Evaluate Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater Tricuspid Regurgitation (TRILUMINATE)
Enrollment Status: Completed
Publish Date: November 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
European Study Evaluating the EMBLOK Cerebral Embolic Protection System During Transcatheter Aortic Valve Replacement (TAVR)
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Device, Drug
Study Drug: Optimal Medical treatment
Study Phase: Phase 4
Magic Touch Sirolimus Coated Balloon (Concept Medical) Versus SeQuent Pease Neo Paclitaxel Coated Balloon (Bbraun) for the Treatment of de Novo Coronary Artery Lesions in Small Vessels
Magic Touch Sirolimus Coated Balloon (Concept Medical) Versus SeQuent Pease Neo Paclitaxel Coated Balloon (Bbraun) for the Treatment of de Novo Coronary Artery Lesions in Small Vessels
Enrollment Status: Unknown
Publish Date: October 05, 2022
Intervention Type: Device
Study Phase: Not Applicable
Evaluation of a Thin Strut Metallic Stent: the Elixir DynamXTM Novolimus Eluting Coronary Bioadaptor System
Evaluation of a Thin Strut Metallic Stent: the Elixir DynamXTM Novolimus Eluting Coronary Bioadaptor System
Enrollment Status: Completed
Publish Date: July 20, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip® Devices (EXPAND)
A Contemporary, Prospective Study Evaluating Real-world Experience of Performance and Safety for the Next Generation of MitraClip® Devices (EXPAND)
Enrollment Status: Completed
Publish Date: February 16, 2022
Intervention Type: Device
Prove ART (Abluminal Reservoir Technology) Clinical Benefit in Alla Comers Patients
Prove ART (Abluminal Reservoir Technology) Clinical Benefit in Alla Comers Patients
Enrollment Status: Completed
Publish Date: July 20, 2021
Intervention Type: Device
Study Phase: Not Applicable
POST-MARKET EVALUATION OF DESolve® NOVOLIMUS ELUTING BIORESORBABLE CORONARY SCAFFOLD SYSTEM IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS
POST-MARKET EVALUATION OF DESolve® NOVOLIMUS ELUTING BIORESORBABLE CORONARY SCAFFOLD SYSTEM IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS
Enrollment Status: Completed
Publish Date: April 08, 2020
Intervention Type: Device
Study Phase: Not Applicable
Prospective Multi-Center, Single Arm Post-Market Study (PMS) of the Shockwave Medical, Inc. Coronary Lithoplasty® System in Coronary Arteries
Prospective Multi-Center, Single Arm Post-Market Study (PMS) of the Shockwave Medical, Inc. Coronary Lithoplasty® System in Coronary Arteries
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Device
Study Phase: Not Applicable
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
The RELIEF Trial: REduction or eLimination of mItral rEgurgitation in Degenerative or Functional Mitral Regurgitation With the CardiAQ-Edwards™ Transcatheter Mitral Valve
Enrollment Status: Withdrawn
Publish Date: January 09, 2018
Intervention Type: Device
Study Phase: Phase 1/Phase 2
View 14 Less Clinical Trials

1061 Total Publications

TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review.
TMVR for the Treatment of Mitral Regurgitation: A State-of-the-Art Review.
Journal: Circulation. Cardiovascular interventions
Published: September 10, 2025
Similar Doctors
Distinguished in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Daniel I. Chikvashvili
Cardiology
Distinguished in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Daniel I. Chikvashvili
Cardiology
11960 Metropolitan Ave, 
Kew Gardens, NY 
 (11.0 miles away)
718-916-9757
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Chikvashvili is a Cardiologist in Kew Gardens, New York. Dr. Chikvashvili is rated as a Distinguished provider by MediFind in the treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. His top areas of expertise are Unstable Angina, Metabolic Syndrome, Myocardial Contusion, Gastrostomy, and Endoscopy.

Bette Kim
Distinguished in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Bette Kim
Cardiology
Distinguished in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Bette Kim
Cardiology

New York University

530 1st Ave, 
New York, NY 
 (7.0 miles away)
212-263-7300
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bette Kim is a Cardiologist in New York, New York. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. Her top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, and Subvalvular Aortic Stenosis.

Distinguished in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Barry L. Huppert
Cardiology
Distinguished in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Dr. Barry L. Huppert
Cardiology

North Shore Medical Group Of The Mount Sinai School Of Medicine

3131 Kings Hwy, Suite 3 03, 
Brooklyn, NY 
 (15.4 miles away)
718-758-7022
Languages Spoken:
English
See accepted insurances

Barry Huppert is a Cardiologist in Brooklyn, New York. Dr. Huppert is rated as a Distinguished provider by MediFind in the treatment of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. His top areas of expertise are Mitral Valve Regurgitation, Supravalvular Aortic Stenosis, Necrosis, Endoscopy, and Pacemaker Implantation.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Colombo's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 13 Advanced Conditions
View All 26 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile